Real-World Retrospective Safety Analysis in Patients Treated With OnabotulinumtoxinA for Multiple Therapeutic Indications Over Repeat Treatment Periods
Objective: To evaluate the real-world safety of onabotulinumtoxinA (onabotA) use over repeat treatment periods (TPs) in patients (pts) with concomitant multiple therapeutic indications. Background: In…Predictors of Response to Botulinum Toxin Treatment in Patients With Hemifacial Spasm:A Prospective Study
Objective: To study the predictors of Good and Bad outcome and the impact on quality of life of patients with HFS following Botulinum toxin treatment.…Diaphragmatic flutter – when the diaphragm does not obey
Objective: clonic twitching of the rectus abdominis muscle and tonic spasm of the diaphragm Background: 61-year-old patient seeking medical help for difficulties lasting about a…Real-world retrospective safety analysis of onabotulinumtoxinA for the treatment of patients with concurrent cervical dystonia and chronic migraine
Objective: To assess the real-world safety of onabotulinumtoxinA (onabotA) for the concomitant treatment of cervical dystonia (CD) and chronic migraine (CM). Background: In the United…Hemifacial Spasm: Recent experience in a movement disorders reference center in Chile
Objective: To analyze the demographic characteristics of patients with HFS and their response to different BoNT at the center for movement disorders CETRAM in Santiago,…Botulinum toxin-A in head and upper extremities tremor. A hand-made option
Objective: This was a 24-week open-label study to assess the role of BoNT-A injections for various types of hand and head tremor Background: Focal treatment…Validation and psychometric properties of the Thai version of the hemifacial spasm grading questionnaire (HFS score) for physician-assessed clinical involvement and patient-reported health-related quality of life: a prospective observational study
Objective: The primary aim was translation to thai and cognitive debriefing of the thai version of the hfs score in patients with hfs. The secondary…SYNCHRONIZE: Real-world retrospective safety analysis in patients treated with onabotulinumtoxinA for more than one therapeutic indication
Objective: Report real-world safety of onabotulinumtoxinA used concomitantly for multiple therapeutic indications. Background: Therapeutic onabotulinumtoxinA is approved in the US for 12 indications, some of…IncobotulinumtoxinA to treat sialorrhea in Parkinson’s disease: a real-life study: 4-year interim results
Objective: We evaluate the long-term efficacy and safety of incobotulinumtoxinA injections in advanced Parkinson’s disease (PD) patients suffering from sialorrhea. Background: Sialorrhea is frequently a…Putting the patient’s voice at the venter: Tracking the impact of botulinum neurotoxin therapy for movement disorders using patient-reported outcomes
Objective: To investigate how patient reported outcomes (PROs) perform to document the effects of a botulinum neurotoxin (BONT) treatment of movement disorders in the clinical…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 13
- Next Page »